New Cosponsor — Oct 15, 2009
New Cosponsor: Rep. Don Young [R-AK0]
The bill now has 16 cosponsors (8 Republicans, 8 Democrats).
Mar 11, 2009
111th Congress, 2009–2010
This bill was introduced on March 11, 2009, in a previous session of Congress, but was not enacted.
Representative for California's 30th congressional district
Read Text »
Last Updated: Mar 11, 2009
Length: 52 pages
To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes.
3/11/2009--Introduced.Promoting Innovation and Access to Life-Saving Medicine Act - Amends the Public Health Service Act to provide for the licensing of biosimilar and interchangeable biological products. Defines "biosimilar" and "interchangeability" ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 1427”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 1427 — 111th Congress: Promoting Innovation and Access to Life-Saving Medicine Act. Retrieved from https://www.govtrack.us/congress/bills/111/hr1427
“H.R. 1427 — 111th Congress: Promoting Innovation and Access to Life-Saving Medicine Act.” www.GovTrack.us. 2009. November 30, 2015 <https://www.govtrack.us/congress/bills/111/hr1427>
|title=H.R. 1427 (111th)
|accessdate=November 30, 2015
|author=111th Congress (2009)
|date=March 11, 2009
|quote=Promoting Innovation and Access to Life-Saving Medicine Act